Sedative Toxidrome

AGENTS

  • opioids
  • benzodiazepines
  • barbiturates
  • baclofen (may mimic brain death, suspect in MS patients)
  • clonidine (mimics opioid toxidrome with marked bradycardia and hypotension)
  • GHB

CLINICAL FEATURES

  • sedation
  • coma
  • pupillary changes
  • respiratory and cardiovascular depression

INVESTIGATIONS

  • urine drug screen – not useful acutely, many drawbacks

SPECIFIC MANAGEMENT AND TRIGGERS FOR INTERVENTION

Opioids

  • naloxone: titrated doses until reversal of respiratory depression -> may require an infusion
  • dose: 0.04-2mg IV/IM/SC/ INH/IN -> 1-10mcg/kg/hr
  • best to give in small increments while providing respiratory support

Barbiturates

  • supportive care
  • multiple doses of activated charcoal
  • alkaline diuresis
  • haemoperfusion

Benzodiazepines

  • supportive care
  • avoid flumazenil if possible – may precipitate withdrawal or intractable seizures
  • consider flumazenil in pediatric ingestion or if benzodiazepines were administered for procedural sedation
  • flumazenil: titrated doses until reversal of respiratory depression -> may require an infusion
  • dose: 0.2mg IV -> 0.1-0.4mg/hr

Clonidine

  • supportive care
  • trial naloxone

GHB

  • supportive care
  • coma should resolve <6 hours, unless diagnosis wrong or re-ingestion!

Baclofen

  • supportive care
  • like barbiturates, may mimic brain death

CCC Toxicology Series

CCC 700 6

Critical Care

Compendium

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.